{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:29:19Z","timestamp":1781134159449,"version":"3.54.1"},"reference-count":63,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2015,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Although experimental data regarding cross-protection of horse West Nile virus (WNV) vaccines against lineage 2 infections exist, the cross-protective efficacy of these vaccines under field conditions has not been demonstrated. This study was conducted to evaluate the capability of an inactivated lineage 1 vaccine (Equip WNV) to protect against natural infections from the Nea Santa-Greece-2010 lineage 2 strain. In total, 185 WNV-seronegative horses in Thessaloniki, Greece, were selected during 2 consecutive years (2011 and 2012); 140 were immunized, and 45 were used as controls. Horses were examined for signs compatible with WNV infection. Neutralizing antibody titers against the Greek strain and the PaAn001\/France lineage 1 strain were determined in immunized horses. WNV circulation was detected during both years in the study area. It was estimated that 37% and 27% of the horses were infected during 2011 and 2012, respectively. Three control animals developed clinical signs, and the WNV diagnosis was confirmed. Signs related to WNV infection were not observed in the vaccinated animals. The nonvaccinated animals had a 7.58% \u00b1 1.82% higher chance of exhibiting signs than immunized animals (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.05). Neutralizing antibodies raised against both strains in all immunized horses were detectable 1 month after the initial vaccination course. The cross-protective capacity of the lowest titer (1:40) was evident in 19 animals which were subsequently infected and did not exhibit signs. Neutralizing antibodies were detectable until the annual booster, when strong anamnestic responses were observed (geometrical mean titer ratio [GMTR] for lineage 1 of 30.2; GMTR for lineage 2 of 27.5). The results indicate that Equip WNV is capable of inducing cross-protection against natural infections from a virulent lineage 2 WNV strain in horses.\n          <\/jats:p>","DOI":"10.1128\/cvi.00302-15","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T01:59:41Z","timestamp":1437011981000},"page":"1040-1049","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":15,"title":["Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions"],"prefix":"10.1128","volume":"22","author":[{"given":"Serafeim C.","family":"Chaintoutis","sequence":"first","affiliation":[{"name":"Diagnostic Laboratory, Department of Clinical Sciences, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Diakakis","sequence":"additional","affiliation":[{"name":"Equine Unit, Companion Animal Clinic, Department of Clinical Sciences, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Papanastassopoulou","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology and Infectious Diseases, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Banos","sequence":"additional","affiliation":[{"name":"Department of Animal Production, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece"},{"name":"SRUC, Easter Bush, Midlothian, Scotland, United Kingdom"},{"name":"The Roslin Institute, Royal (Dick) School of Veterinary Science, Easter Bush, Midlothian, Scotland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysostomos I.","family":"Dovas","sequence":"additional","affiliation":[{"name":"Diagnostic Laboratory, Department of Clinical Sciences, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-003-1085-1"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1108.050289a"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"47S","DOI":"10.1046\/j.1365-2672.94.s1.6.x","article-title":"Migratory birds and West Nile virus","volume":"94","author":"Rappole JH","year":"2003","unstructured":"Rappole JH, Hub\u00e1lek Z. 2003. Migratory birds and West Nile virus. J Appl Microbiol 94(Suppl):47S\u201358S.","journal-title":"J Appl Microbiol"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4269\/ajtmh.2007.77.358","article-title":"Serologic evidence of West Nile virus infections in wild birds captured in Germany","volume":"77","author":"Linke S","year":"2007","unstructured":"Linke S, Niedrig M, Kaiser A, Ellerbrok H, M\u00fcller K, M\u00fcller T, Conraths FJ, M\u00fchle RU, Schmidt D, K\u00f6ppen U, Bairlein F, Berthold P, Pauli G. 2007. Serologic evidence of West Nile virus infections in wild birds captured in Germany. Am J Trop Med Hyg 77:358\u2013364.","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ento.53.103106.093258"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph10104869"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cimid.2004.03.009"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1108.050289b"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.2746\/042516400777612080"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/vr.151.2.47"},{"key":"e_1_3_2_12_2","first-page":"469","article-title":"West Nile virus encephalomyelitis in horses in Ontario: 28 cases","volume":"44","author":"Weese JS","year":"2003","unstructured":"Weese JS, Baird JD, DeLay J, Kenney DG, Staempfli HR, Viel L, Parent J, Smith-Maxie L, Poma R. 2003. West Nile virus encephalomyelitis in horses in Ontario: 28 cases. Can Vet J 44:469\u2013473.","journal-title":"Can Vet J"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1506.081515"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2011.0715.x"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1603.091033"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1204.051379"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.2174\/1874357901004020029"},{"key":"e_1_3_2_18_2","first-page":"195","article-title":"The ecology and epidemiology of West Nile virus in Africa, Europe and Asia","volume":"267","author":"Murgue B","year":"2002","unstructured":"Murgue B, Zeller H, Deubel V. 2002. The ecology and epidemiology of West Nile virus in Africa, Europe and Asia. Curr Top Microbiol Immunol 267:195\u2013221.","journal-title":"Curr Top Microbiol Immunol"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2012.02.018"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph10126534"},{"key":"e_1_3_2_21_2","unstructured":"Hellenic Center for Disease Control and Prevention. 2013. Report on West Nile virus epidemic. http:\/\/goo.gl\/lsJaeC."},{"key":"e_1_3_2_22_2","volume-title":"Surveillance and early warning of West Nile virus lineage 2 using domestic pigeons and backyard chickens","author":"Chaintoutis SC","year":"2014","unstructured":"Chaintoutis SC, Gewehr S, Danis K, Kalaitzopoulou S, Antalis V, Papanastassopoulou M, Mourelatos S, Panagiotopoulos T, Hadjichristodoulou C, Dovas CI. 2014. Surveillance and early warning of West Nile virus lineage 2 using domestic pigeons and backyard chickens. In Proceedings of the 19th Congress of the European Society for Vector Ecology, Thessaloniki, Greece."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0909.030025"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1637\/0005-2086(2007)51[573:DVOTAC]2.0.CO;2"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.11.056"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2009.0029"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph10116049"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1086\/376871"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.3390\/v5102384"},{"key":"e_1_3_2_30_2","first-page":"221","article-title":"Equine vaccine for West Nile virus","volume":"114","author":"Ng T","year":"2003","unstructured":"Ng T, Hathaway D, Jennings N, Champ D, Chiang YW, Chu HJ. 2003. Equine vaccine for West Nile virus. Dev Biol (Basel) 114:221\u2013227.","journal-title":"Dev Biol (Basel)"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00249-07"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.2746\/042516407X248476"},{"key":"e_1_3_2_33_2","unstructured":"Intervet Schering-Plough Animal Health. EquiNile with Havlogen: material safety data sheet no. SP002579. http:\/\/www.merck-animal-health-usa.com\/products\/equi-nile_with_havlogen\/overview.aspx."},{"key":"e_1_3_2_34_2","unstructured":"European Medicines Agency. 2015. EPAR product information: Equip WNV. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/veterinary\/000137\/WC500063683.pdf."},{"key":"e_1_3_2_35_2","unstructured":"European Medicines Agency. 2015. EPAR summary for the public: Proteq West Nile. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Summary_for_the_public\/veterinary\/002005\/WC500110366.pdf."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.04.058"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.06.059"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.07.093"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4269\/ajtmh.2006.75.337","article-title":"Enhanced early West Nile virus infection in young chickens infected by mosquito bite: effect of viral dose","volume":"75","author":"Styer LM","year":"2006","unstructured":"Styer LM, Bernard KA, Kramer LD. 2006. Enhanced early West Nile virus infection in young chickens infected by mosquito bite: effect of viral dose. Am J Trop Med Hyg 75:337\u2013345.","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cimid.2014.01.004"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2012.1176"},{"key":"e_1_3_2_42_2","volume-title":"Chapman & Hall\/CRC tests in statistical science","author":"Altman DG","year":"2006","unstructured":"Altman DG. 2006. Practical statistics for medical research, 2nd ed. Chapman & Hall\/CRC tests in statistical science. Chapman & Hall\/CRC, London, United Kingdom.","edition":"2"},{"key":"e_1_3_2_43_2","volume-title":"Principles of biostatistics","author":"Pagano M","year":"2000","unstructured":"Pagano M, Gauvreau K. 2000. Principles of biostatistics, 2nd ed. Brooks\/Cole, Belmont, CA.","edition":"2"},{"key":"e_1_3_2_44_2","unstructured":"Deeks JJ Higgins JPT. 2010. Statistical algorithms in Review Manager 5. http:\/\/ims.cochrane.org\/revman\/documentation\/Statistical-methods-in-RevMan-5.pdf."},{"key":"e_1_3_2_45_2","volume-title":"ASReml user guide release 3.0","author":"Gilmour AR","year":"2009","unstructured":"Gilmour AR, Gogel BJ, Cullis BR, Thompson R. 2009. ASReml user guide release 3.0. VSN International Ltd., Hemel Hempstead, United Kingdom."},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/mst197"},{"key":"e_1_3_2_47_2","first-page":"95","article-title":"BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT","volume":"41","author":"Hall TA","year":"1999","unstructured":"Hall TA. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT. Nucl Acids Symp Ser 41:95\u201398.","journal-title":"Nucl Acids Symp Ser"},{"issue":"31","key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"pii=19933","DOI":"10.2807\/ese.16.31.19933-en","article-title":"Evidence of enzootic circulation of West Nile virus (Nea Santa-Greece-2010, lineage 2), Greece, May to July 2011","volume":"16","author":"Chaskopoulou A","year":"2011","unstructured":"Chaskopoulou A, Dovas CI, Chaintoutis SC, Bouzalas I, Ara G, Papanastassopoulou M. 2011. Evidence of enzootic circulation of West Nile virus (Nea Santa-Greece-2010, lineage 2), Greece, May to July 2011. Euro Surveill 16(31):pii=19933. http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=19933.","journal-title":"Euro Surveill"},{"key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3201\/eid1905.121418","article-title":"West Nile virus lineage 2 strain in Greece, 2012","volume":"19","author":"Chaintoutis SC","year":"2013","unstructured":"Chaintoutis SC, Chaskopoulou A, Chassalevris T, Koehler PG, Papanastassopoulou M, Dovas CI. 2013. West Nile virus lineage 2 strain in Greece, 2012. Emerg Infect Dis 19:827\u2013829.","journal-title":"Emerg Infect Dis"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/tbed.12334"},{"key":"e_1_3_2_51_2","first-page":"397","volume-title":"Preliminary data regarding the subclinical exposure rate of horses to West Nile virus during the 2001 Florida enzootic","author":"Long MT","year":"2003","unstructured":"Long MT, Porter MB, Hernandez J, Giguere S, Fontaine GL, Jodoin EA, Gillis KD. 2003. Preliminary data regarding the subclinical exposure rate of horses to West Nile virus during the 2001 Florida enzootic, p 397\u2013398. In Proceedings of the 49th Annual Meeting of the American Association of Equine Practitioners, New Orleans, LA."},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1051\/vetres:2004022"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1051\/vetres:2006045"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.2460\/javma.2005.226.240"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetimm.2008.08.007"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.4102\/jsava.v84i1.1052"},{"key":"e_1_3_2_57_2","first-page":"13091","article-title":"Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein","volume":"76","author":"Beasley DWC","year":"2002","unstructured":"Beasley DWC, Barrett ADT. 2002. Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J Virol 76:13091\u201313100.","journal-title":"J Virol"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1240"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.02.020"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01732-06"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.02.011"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.24.13975-13986.2004"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00080-06"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.3390\/v5112856"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00302-15","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00302-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T06:07:10Z","timestamp":1623564430000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00302-15"}},"subtitle":[],"editor":[{"given":"S. A.","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.1128\/CVI.00302-15"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00302-15","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"2015-05-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-07-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-08-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}